Discharge Destination and Postoperative Mobility in Hip Fracture Patients
Authors: Bell, Alice C; Stennett, Christina A; Torrie, Arissa M; Li, Vivian; Okhuereigbe, David O; Sciadini, Marcus F; O'Toole, Robert V; O'Hara, Nathan N
Source journal: Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews (2026-11-01)
DOI: e26.00372
Abstract
INTRODUCTION: The COVID-19 pandemic shifted clinical practice, with more patients discharged home rather than postacute care facilities. We evaluated how reduced use of postacute care facilities affected outcomes for hip fracture patients. METHODS: Using National Surgical Quality Improvement Program (NSQIP) data (2016 to 2020), we conducted a cohort study of patients 60 years or older with a surgically treated hip fracture. The primary exposure was the interaction of discharge to a postacute facility with admission year (2016 to 2019 vs. 2020). The primary outcome was mobility aid use 30 days after injury. Secondary outcomes included 30-day readmission, revision surgery, delirium, mortality, and length of stay. We used a difference-in-differences analysis to estimate effects of time-dependent changes in discharge practices. RESULTS: Among 56,125 patients, discharge to postacute facilities declined from 77.4% (2016 to 2019) to 67.6% (2020) (difference, -9.7%; 95% CI, -10.6 to -8.8%; P < 0.001). This change was not associated with a difference in mobility aid use (difference, -0.3%; 95% CI, -2.0 to 1.4%, P = 0.76) but with a 1.5% decline in readmissions (95% CI, -3.0% to 0.1%; P = 0.04). Revision surgery, delirium, mortality, and length of stay were unaffected. Home discharge was more likely among patients taking preinjury bone medication (OR, 1.14; P < 0.01) and with preoperative delirium (OR, 1.18; P = 0.01), but less likely with dementia (OR, 0.71; P < 0.001). CONCLUSION: Approximately 10% of hip fracture patients discharged to postacute care facilities might be discharged home without worsening outcomes. Patients on preinjury bone medications, those with preoperative delirium, and without dementia could benefit most.
Related topics
Related open access articles
- CHALLENGES IN THE DIAGNOSIS AND TREATMENT OF PATIENTS WITH COLORECTAL CANCER AND COVID-19 COINFECTION - CASE REPORT
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- The use of non-invasive ventilation (NIV) in the treatment of patients with COVID-19
- Application of Nanotechnology in Treatment of COVID-19
- Nano Platforms in Combatting COVID-19: Unveiling Antiviral Strategies and Challenges
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.